Camilla Zimmermann MD PhD ری ٹویٹ کیا

Rethinking Novel Therapy Use in End-of-Life Cancer Care
Research from @UHN’s @ZimmTeamLab reports a rising use of systemic anticancer therapies at the end of life—primarily driven by cancer immunotherapy. This trend raises important concerns.
@JCO_ASCO: doi.org/10.1200/JCO-24…
English
























